Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $77.8 million.

  • AtriCure's Total Current Liabilities rose 458.01% to $77.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.8 million, marking a year-over-year increase of 458.01%. This contributed to the annual value of $73.4 million for FY2024, which is 153.55% down from last year.
  • AtriCure's Total Current Liabilities amounted to $77.8 million in Q3 2025, which was up 458.01% from $68.8 million recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Total Current Liabilities peaked at $82.5 million during Q3 2023, and registered a low of $47.4 million during Q1 2022.
  • For the 5-year period, AtriCure's Total Current Liabilities averaged around $64.5 million, with its median value being $61.3 million (2024).
  • As far as peak fluctuations go, AtriCure's Total Current Liabilities soared by 7721.28% in 2021, and later tumbled by 1896.58% in 2022.
  • AtriCure's Total Current Liabilities (Quarter) stood at $56.4 million in 2021, then rose by 3.45% to $58.4 million in 2022, then increased by 27.7% to $74.6 million in 2023, then dropped by 1.54% to $73.4 million in 2024, then increased by 6.01% to $77.8 million in 2025.
  • Its last three reported values are $77.8 million in Q3 2025, $68.8 million for Q2 2025, and $61.2 million during Q1 2025.